Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT00517790 · COMPLETED
Trial details
- NCT number
- NCT00517790
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2011-06-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.